| Combination of ruxolitinib and eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome: a controlled study V Giudice, P Pagliano, A Vatrella, A Masullo, S Poto, BM Polverino, ... Frontiers in pharmacology 11, 857, 2020 | 115 | 2020 |
| PD-L1 dysregulation in COVID-19 patients F Sabbatino, V Conti, G Franci, C Sellitto, V Manzo, P Pagliano, ... Frontiers in immunology 12, 695242, 2021 | 69 | 2021 |
| Characteristics of viral pneumonia in the COVID-19 era: an update P Pagliano, C Sellitto, V Conti, T Ascione, S Esposito Infection 49 (4), 607-616, 2021 | 65 | 2021 |
| Cardiovascular outcomes and mortality associated with discontinuing statins in older patients receiving polypharmacy F Rea, A Biffi, R Ronco, M Franchi, S Cammarota, A Citarella, V Conti, ... JAMA network open 4 (6), e2113186-e2113186, 2021 | 56 | 2021 |
| Identification of drug interaction adverse events in patients with COVID-19: a systematic review V Conti, C Sellitto, M Torsiello, V Manzo, E De Bellis, B Stefanelli, ... JAMA Network Open 5 (4), e227970-e227970, 2022 | 34 | 2022 |
| Experimental pharmacotherapy for COVID-19: the latest advances P Pagliano, G Scarpati, C Sellitto, V Conti, AM Spera, T Ascione, O Piazza, ... Journal of experimental pharmacology, 1-13, 2021 | 32 | 2021 |
| Pharmacogenetics of carbamazepine and valproate: focus on polymorphisms of drug metabolizing enzymes and transporters T Iannaccone, C Sellitto, V Manzo, F Colucci, V Giudice, B Stefanelli, ... Pharmaceuticals 14 (3), 204, 2021 | 27 | 2021 |
| Different cell cycle modulation in SKOV-3 ovarian cancer cell line by anti-HIV drugs A Perna, A Lucariello, C Sellitto, I Agliata, MA Carleo, V Sangiovanni, ... Oncology Research 25 (9), 1617, 2017 | 26 | 2017 |
| Small leucine rich proteoglycans are differently distributed in normal and pathological endometrium A Lucariello, E Trabucco, O Boccia, A Perna, C Sellitto, MA Castaldi, ... in vivo 29 (2), 217-222, 2015 | 23 | 2015 |
| An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19) P Pagliano, C Sellitto, G Scarpati, T Ascione, V Conti, G Franci, O Piazza, ... Expert Opinion on Drug Discovery 17 (1), 9-18, 2022 | 20 | 2022 |
| Biomarkers to personalize the treatment of rheumatoid arthritis: focus on autoantibodies and pharmacogenetics V Conti, G Corbi, M Costantino, E De Bellis, V Manzo, C Sellitto, ... Biomolecules 10 (12), 1672, 2020 | 19 | 2020 |
| Long COVID: clinical framing, biomarkers, and therapeutic approaches V Conti, G Corbi, F Sabbatino, D De Pascale, C Sellitto, B Stefanelli, ... Journal of Personalized Medicine 13 (2), 334, 2023 | 18 | 2023 |
| Effect of tocilizumab in reducing the mortality rate in COVID-19 patients: a systematic review with meta-analysis V Conti, G Corbi, C Sellitto, F Sabbatino, C Maci, N Bertini, E De Bellis, ... Journal of Personalized Medicine 11 (7), 628, 2021 | 17 | 2021 |
| Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study V Raparelli, D Pastori, SF Pignataro, AR Vestri, P Pignatelli, R Cangemi, ... Internal and Emergency Medicine 13, 651-660, 2018 | 16 | 2018 |
| Role of FAP48 in HIV‐associated lipodystrophy V Esposito, L Manente, A Lucariello, A Perna, R Viglietti, M Gargiulo, ... Journal of Cellular Biochemistry 113 (11), 3446-3454, 2012 | 16 | 2012 |
| CD34 expression in the stromal cells of alveolar adenoma N De Rosa, A Maiorino, I De Rosa, C Curcio, C Sellitto, D Amore Case Reports in Medicine 2012, 2012 | 15 | 2012 |
| Adverse events associated with BNT162b2 and AZD1222 vaccines in the real world: Surveillance report in a single Italian vaccine center M Costantino, C Sellitto, V Conti, G Corbi, F Marongiu, G Genovese, ... Journal of Clinical Medicine 11 (5), 1408, 2022 | 14 | 2022 |
| The need of a multicomponent guiding approach to personalize clopidogrel treatment C Valeria, S Carmine, M Valentina, I Teresa, C Maria, T Martina, ... The pharmacogenomics journal 21 (2), 116-127, 2021 | 14 | 2021 |
| BPIFB4 circulating levels and its prognostic relevance in COVID-19 E Ciaglia, V Lopardo, F Montella, C Sellitto, V Manzo, E De Bellis, ... The Journals of Gerontology: Series A 76 (10), 1775-1783, 2021 | 13 | 2021 |
| The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19) P Pagliano, C Sellitto, T Ascione, G Scarpati, V Folliero, O Piazza, ... Expert Opinion on Drug Discovery 17 (12), 1299-1311, 2022 | 12 | 2022 |
